Publicaciones en las que colabora con MARÍA DEL ROCÍO HERRERO VANRELL (18)

2024

  1. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Influence of sex on chronic steroid-induced glaucoma: 24-Weeks follow-up study in rats

    Experimental Eye Research, Vol. 238

2023

  1. Microesferas biodegradables cargadas con dexametasona para el desarrollo de modelos animales de glaucoma crónico: la influencia de la adición de fibronectina por doble emulsión

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres

    Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374

2021

  1. Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

    Biomedicines, Vol. 9, Núm. 12

  2. Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up

    Biomedicines, Vol. 9, Núm. 6

  3. Influence of sex on neuroretinal degeneration: Six-month follow-up in rats with chronic glaucoma

    Investigative Ophthalmology and Visual Science, Vol. 62, Núm. 13

  4. Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

    Drug Delivery, Vol. 28, Núm. 1, pp. 2427-2446

  5. Modelo animal de glaucoma crónico inducido con microesferas biodegradables: influencia de la adición de dexametasona

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 60-62

  6. Novel use of plga microspheres to create an animal model of glaucoma with progressive neuroretinal degeneration

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20

  7. The effect of a triple combination of bevacizumab, sodium hyaluronate and a collagen matrix implant in a trabeculectomy animal model

    Pharmaceutics, Vol. 13, Núm. 6

2017

  1. Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma

    Advances in Therapy, Vol. 34, Núm. 2, pp. 378-395

  2. Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits

    European Journal of Pharmaceutical Sciences, Vol. 103, pp. 19-26

2012

  1. Effects of corneal thickness on the intraocular penetration of travoprost 0.004%

    Eye (Basingstoke), Vol. 26, Núm. 7, pp. 972-975

  2. Recent patents and developments in glaucoma biomarkers

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234

2011

  1. Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers

    Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 6, pp. 3548-3556

  2. Estudio comparativo de la eficacia hipotensora y de las variaciones en la amplitud de pulso ocular entre las combinaciones fijas dorzolamida/timolol y brinzolamida/timolol

    Archivos de la Sociedad Española de Oftalmologia, Vol. 86, Núm. 5, pp. 149-153

  3. Performance of the rebound, noncontact and Goldmann applanation tonometers in routine clinical practice

    Acta Ophthalmologica, Vol. 89, Núm. 7, pp. 676-680